Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12CAndreas Weiss, Saskia M. Brachmann, Claudio Bomio-Confaglia et al.|Cancer Discovery|2022Cited by 134
Enhanced replication of SARS-CoV-2 Omicron BA.2 in human forebrain and midbrain organoidsYuxin Hou, Hin Chu, Chang Li et al.|Signal Transduction and Targeted Therapy|2022Cited by 29